708
Views
25
CrossRef citations to date
0
Altmetric
Article

Emerging roles for Interleukin-11 in disease

, &
Pages 1-11 | Received 14 Mar 2019, Accepted 13 May 2019, Published online: 04 Jun 2019

References

  • Agthe, M., J. Brugge, Y. Garbers, M. Wandel, B. Kespohl, P. Arnold, C. M. Flynn., et al. 2018. “Mutations in Craniosynostosis Patients Cause Defective Interleukin-11 Receptor Maturation and Drive Craniosynostosis-like Disease in Mice.” Cell Reports 25 (1): 10–18.e5.
  • Agthe, M., Y. Garbers, J. Grotzinger, and C. Garbers. 2018. “Two N-Linked Glycans Differentially Control Maturation, Trafficking and Proteolysis, but Not Activity of the IL-11 Receptor.” Cellular Physiology and Biochemistry 45 (5): 2071–2085.
  • Andoh, A., Z. Zhang, O. Inatomi, S. Fujino, Y. Deguchi, Y. Araki, T. Tsujikawa., et al. 2005. “Interleukin-22, a Member of the IL-10 Subfamily, Induces Inflammatory Responses in Colonic Subepithelial Myofibroblasts.” Gastroenterology 129 (3): 969–984.
  • Barton, V. A., M. A. Hall, K. R. Hudson, and J. K. Heath. 2000. “Interleukin-11 Signals through the Formation of a Hexameric Receptor Complex.” Journal of Biological Chemistry 275 (46): 36197–36203.
  • Bockhorn, J., R. Dalton, C. Nwachukwu, S. Huang, A. Prat, K. Yee, Y. F. Chang., et al. 2013. “MicroRNA-30c Inhibits Human Breast Tumour Chemotherapy Resistance by Regulating TWF1 and IL-11.” Nature Communications 4:1393.
  • Boerma, M., J. Wang, A. F. Burnett, A. D. Santin, J. J. Roman, and M. Hauer-Jensen. 2007. “Local Administration of Interleukin-11 Ameliorates Intestinal Radiation Injury in Rats.” Cancer Research 67 (19): 9501.
  • Boulanger, M. J., D. C. Chow, E. E. Brevnova, and K. C. Garcia. 2003. “Hexameric Structure and Assembly of the Interleukin-6/IL-6 Alpha-Receptor/gp130 Complex.” Science 300 (5628): 2101–2104.
  • Buzzelli, J. N., L. O’Connor, M. Scurr, S. Chung Nien Chin, A. Catubig, G. Z. Ng, M. Oshima, et al. 2018. “Overexpression of IL-11 Promotes Premalignant Gastric Epithelial Hyperplasia in Isolation from Germline gp130-JAK-STAT3 Driver Mutations.” American Journal of Physiology-Gastrointestinal and Liver Physiology 316:G251–G262.
  • Cai, W. L., W. D. Huang, B. Li, T. R. Chen, Z. X. Li, C. L. Zhao, H. Y. Li, Y. M. Wu, W. J. Yan, and J. R. Xiao. 2018. “microRNA-124 Inhibits Bone Metastasis of Breast Cancer by Repressing Interleukin-11.” Molecular Cancer 17 (1): 9.
  • Calon, A., E. Espinet, S. Palomo-Ponce, D. V. Tauriello, M. Iglesias, M. V. Cespedes, M. Sevillano, et al. 2012. “Dependency of Colorectal Cancer on a TGF-Beta-Driven Program in Stromal Cells for Metastasis Initiation.” Cancer Cell 22 (5): 571–584.
  • Cardó-Vila, M., S. Marchiò, M. Sato, F. I. Staquicini, T. L. Smith, J. K. Bronk, G. Yin, et al. 2016. “Interleukin-11 Receptor is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical Activity.” American Journal of Pathology 186 (8): 2162–2170.
  • Chen, Z., X. Chen, R. Xie, M. Huang, W. Dong, J. Han, J. Zhang, et al. 2019. “DANCR Promotes Metastasis and Proliferation in Bladder Cancer Cells by Enhancing IL-11-STAT3 Signaling and CCND1 Expression.” Molecular Therapy 27:P326–341.
  • Cork, B. A., T. C. Li, M. A. Warren, and S. M. Laird. 2001. “Interleukin-11 (IL-11) in Human Endometrium: Expression Throughout the Menstrual Cycle and the Effects of Cytokines on Endometrial IL-11 Production in Vitro.” Journal of Reproductive Immunology 50 (1): 3–17.
  • Dams-Kozlowska, H., E. Kwiatkowska-Borowczyk, K. Gryska, and A. Mackiewicz. 2013. “Designer Cytokine Hyper Interleukin 11 (H11) Is a Megakaryopoietic Factor.” International Journal of Medical Sciences 10 (9): 1157–1165.
  • Deguchi, Y., T. Nishina, K. Asano, M. Ohmuraya, Y. Nakagawa, N. Nakagata, T. Sakuma, et al. 2018. “Generation of and Characterization of anti-IL-11 Antibodies Using Newly Established Il11-Deficient Mice.” Biochemical and Biophysical Research Communications 505 (2): 453–459.
  • Disson, O., C. Bleriot, J. M. Jacob, N. Serafini, S. Dulauroy, G. Jouvion, C. Fevre, et al. 2018. “Peyer's Patch Myeloid Cells Infection by Listeria Signals through gp38(+) Stromal Cells and Locks Intestinal Villus Invasion.” The Journal of Experimental Medicine 215 (11): 2936–2954.
  • Du, X., E. T. Everett, G. Wang, W. H. Lee, Z. Yang, and D. A. Williams. 1996. “Murine Interleukin-11 (IL-11) is Expressed at High Levels in the Hippocampus and Expression is Developmentally Regulated in the Testis.” Journal of Cellular Physiology 168 (2): 362–372.
  • Elias, J. A., T. Zheng, O. Einarsson, M. Landry, T. Trow, N. Rebert, and J. Panuska. 1994. “Epithelial Interleukin-11. Regulation by Cytokines, Respiratory Syncytial Virus, and Retinoic Acid.” Journal of Biological Chemistry 269 (35): 22261–22268.
  • Ellerby, H. M., W. Arap, L. M. Ellerby, R. Kain, R. Andrusiak, G. D. Rio, S. Krajewski, et al. 1999. “Anti-Cancer Activity of Targeted Pro-Apoptotic Peptides.” Nature Medicine 5 (9): 1032–1038.
  • Elshabrawy, H. A., M. V. Volin, A. B. Essani, Z. Chen, I. B. McInnes, K. Van Raemdonck, K. Palasiewicz, et al. 2018. “IL-11 Facilitates a Novel Connection between RA Joint Fibroblasts and Endothelial Cells.” Angiogenesis 21 (2): 215–228.
  • Ernst, M., M. Najdovska, D. Grail, T. Lundgren-May, M. Buchert, H. Tye, V. B. Matthews, et al. 2008. “STAT3 and STAT1 Mediate IL-11-Dependent and Inflammation-Associated Gastric Tumorigenesis in gp130 Receptor Mutant Mice.” Journal of Clinical Investigation 118 (5): 1727–1738.
  • Gao, Y. B., Z. L. Xiang, L. Y. Zhou, Z. F. Wu, J. Fan, H. Y. Zeng, and Z. C. Zeng. 2013. “Enhanced Production of CTGF and IL-11 from Highly Metastatic Hepatoma Cells under Hypoxic Conditions: An Implication of Hepatocellular Carcinoma Metastasis to Bone.” Journal of Cancer Research and Clinical Oncology 139 (4): 669–679.
  • Gibson, R. J., D. M. K. Keefe, F. M. Thompson, J. M. Clarke, G. J. Goland, and A. G. Cummins. 2002. “Effect of Interleukin-11 on Ameliorating Intestinal Damage after Methotrexate Treatment of Breast Cancer in Rats.” Digestive Diseases and Sciences 47 (12): 2751.
  • Goulet, V., M. Hebert, C. Hedberg, E. Laurent, V. Vaillant, H. De Valk, and J. C. Desenclos. 2012. “Incidence of Listeriosis and Related Mortality among Groups at Risk of Acquiring Listeriosis.”  Clinical Infectious Diseases 54 (5): 652–660.
  • Gustafsson, K. L. R., T. Renne, C. Soderberg-Naucler, and L. M. Butler. 2018. “Human Cytomegalovirus Replication Induces Endothelial Cell Interleukin-11.” Cytokine 111:563–566.
  • Haase, M. G., A. Schulze, S. Grover, I. Kemnitz, I. R. Konig, and G. Fitze. 2018. “GT-Repeat Extension in the IL11 Promoter is Associated with Hirschsprung’s Disease (HSCR).” Gene 677:163–168.
  • Hanahan, D., and R. A. Weinberg. 2011. “Hallmarks of Cancer: The Next Generation.” Cell 144 (5): 646–674.
  • Hirano, T., K. Yasukawa, H. Harada, T. Taga, Y. Watanabe, T. Matsuda, S. Kashiwamura, et al. 1986. “Complementary DNA for a Novel Human Interleukin (BSF-2) That Induces B Lymphocytes to Produce Immunoglobulin.” Nature 324 (6092): 73–76.
  • Howlett, M., H. V. Chalinor, J. N. Buzzelli, N. Nguyen, I. R. van Driel, K. M. Bell, J. G. Fox, et al. 2012. “IL-11 is a Parietal Cell Cytokine That Induces Atrophic Gastritis.” Gut 61 (10): 1398–1409.
  • Howlett, M., A. S. Giraud, H. Lescesen, C. B. Jackson, A. Kalantzis, I. R. Van Driel, L. Robb, et al. 2009. “The Interleukin-6 Family Cytokine Interleukin-11 Regulates Homeostatic Epithelial Cell Turnover and Promotes Gastric Tumor Development.” Gastroenterology 136 (3): 967–977.
  • Isaacs, C., N. J. Robert, F. A. Bailey, M. W. Schuster, B. Overmoyer, M. Graham, B. Cai, K. J. Beach, J. W. Loewy, and J. A. Kaye. 1997. “Randomized Placebo-Controlled Study of Recombinant Human Interleukin-11 to Prevent Chemotherapy-Induced Thrombocytopenia in Patients with Breast Cancer Receiving Dose-Intensive Cyclophosphamide and Doxorubicin.” Journal of Clinical Oncology 15 (11): 3368–3377.
  • Jiang, T., Z. Huang, S. Zhang, W. Zou, L. Xiang, X. Wu, Y. Shen, et al. 2018. “miR23b Inhibits Proliferation of SMMC7721 Cells by Directly Targeting IL11.” Molecular Medicine Reports 18 (2): 1591–1599.
  • Kapina, M. A., G. S. Shepelkova, V. G. Avdeenko, A. N. Guseva, T. K. Kondratieva, V. V. Evstifeev, and A. S. Apt. 2011. “Interleukin-11 Drives Early Lung Inflammation during Mycobacterium tuberculosis Infection in Genetically Susceptible Mice.” PLoS One 6 (7): e21878.
  • Karjalainen, K., D. E. Jaalouk, C. Bueso-Ramos, L. Bover, Y. Sun, A. Kuniyasu, W. H. Driessen, et al. 2015. “Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens.” Clinical Cancer Research 21 (13): 3041–3051.
  • Kawaguchi, M., J. Fujita, F. Kokubu, S. K. Huang, T. Homma, S. Matsukura, M. Adachi, and N. Hizawa. 2009. “IL-17F-Induced IL-11 Release in Bronchial Epithelial Cells via MSK1-CREB Pathway.” American Journal of Physiology-Lung Cellular and Molecular Physiology 296 (5): L804–10.
  • Kim, L. H., H. S. Cheong, J. G. Shin, J. M. Seo, D. Y. Kim, J. T. Oh, H. Y. Kim, et al. 2015. “Genetic Variants of IL-11 Associated with Risk of Hirschsprung Disease.” Neurogastroenterology & Motility 27 (10): 1371–1377.
  • Klein, W., G. Rohde, U. Arinir, M. Hagedorn, N. Durig, G. Schultze-Werninghaus, and J. T. Epplen. 2004. “A Promotor Polymorphism in the Interleukin 11 Gene is Associated with Chronic Obstructive Pulmonary Disease.” Electrophoresis 25 (6): 804–808.
  • Klein, W., A. Tromm, T. Griga, H. Fricke, C. Folwaczny, M. Hocke, K. Eitner, M. Marx, N. Duerig, and J. T. Epplen. 2002. “A Polymorphism in the IL11 Gene is Associated with Ulcerative Colitis.” Genes & Immunity 3 (8): 494–496.
  • Kuo, C. L., S. T. Liu, Y. L. Chang, C. C. Wu, and S. M. Huang. 2018. “Zac1 Regulates IL-11 Expression in osteoarthritis.” Oncotarget 9 (65): 32478–32495.
  • Lamertz, L., F. Rummel, R. Polz, P. Baran, S. Hansen, G. H. Waetzig, J. M. Moll, D. M. Floss, and J. Scheller. 2018. “Soluble gp130 Prevents Interleukin-6 and Interleukin-11 Cluster Signaling but Not Intracellular Autocrine Responses.” Science Signaling 11 (550): eaar7388.
  • Lanktree, M. B., Y. Guo, M. Murtaza, J. T. Glessner, S. D. Bailey, N. C. Onland-Moret, G. Lettre, et al. 2011. “Meta-Analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height.” American Journal of Human Genetics 88 (1): 6–18.
  • Lee, C. G., D. Hartl, H. Matsuura, F. M. Dunlop, P. D. Scotney, L. J. Fabri, A. D. Nash, et al. 2008. “Endogenous IL-11 Signaling Is Essential in Th2- and IL-13-Induced Inflammation and Mucus Production.” American Journal of Respiratory Cell and Molecular Biology 39 (6): 739–746.
  • Lewis, V. O., E. Devarajan, M. Cardo-Vila, D. G. Thomas, E. S. Kleinerman, S. Marchio, R. L. Sidman, R. Pasqualini, and W. Arap. 2017. “BMTP-11 Is Active in Preclinical Models of Human Osteosarcoma and a Candidate Targeted Drug for Clinical Translation.” Proceedings of the National Academy of Sciences 114 (30): 8065–8070.
  • Lokau, J., and C. Garbers. 2018. “The Length of the Interleukin-11 Receptor Stalk Determines its Capacity for Classic Signaling.” Journal of Biological Chemistry 293 (17): 6398–6409.
  • Lokau, J., S. Gottert, P. Arnold, S. Dusterhoft, D. Massa Lopez, J. Grotzinger, and C. Garbers. 2018. “The SNP rs4252548 (R112H) Which is Associated with Reduced Human Height Compromises the Stability of IL-11.” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1865 (3): 496–506.
  • Lokau, J., R. Nitz, M. Agthe, N. Monhasery, S. Aparicio-Siegmund, N. Schumacher, J. Wolf, et al. 2016. “Proteolytic Cleavage Governs Interleukin-11 Trans-Signaling.” Cell Reports 14 (7): 1761–1773.
  • Ma, J., X. Song, X. Xu, and Y. Mou. 2018. “Cancer-Associated-Fibroblasts Promote the Chemo-Resistance in Gastric Cancer through Secreting IL-11 Targeting JAK/STAT3/Bcl2 Pathway.”  Cancer Research and Treatment: Official Journal of Korean Cancer Association 51:194–210.
  • Matadeen, R., W. C. Hon, J. K. Heath, E. Y. Jones, and S. Fuller. 2007. “The Dynamics of Signal Triggering in a gp130-Receptor Complex.” Structure 15 (4): 441–448.
  • Mercer, T. R., M. E. Dinger, and J. S. Mattick. 2009. “Long Non-Coding RNAs: Insights into Functions.” Nature Reviews Genetics 10 (3): 155–159.
  • Nagineni, C. N., V. K. Kommineni, A. William, J. J. Hooks, and B. Detrick. 2010. “IL-11 Expression in Retinal and Corneal Cells is Regulated by Interferon-Gamma.” Biochemical and Biophysical Research Communications 391 (1): 287–292.
  • Nieminen, P., N. V. Morgan, A. L. Fenwick, S. Parmanen, L. Veistinen, M. L. Mikkola, P. J. van der Spek, et al. 2011. “Inactivation of IL11 Signaling Causes Craniosynostosis, Delayed Tooth Eruption, and Supernumerary Teeth.” The American Journal of Human Genetics 89 (1): 67–81.
  • Obana, M., M. Maeda, K. Takeda, A. Hayama, T. Mohri, T. Yamashita, Y. Nakaoka, et al. 2010. “Therapeutic Activation of Signal Transducer and Activator of Transcription 3 by Interleukin-11 Ameliorates Cardiac Fibrosis after Myocardial Infarction.” Circulation 121 (5): 684–691.
  • Pasqualini, R., R. E. Millikan, D. R. Christianson, M. Cardó-Vila, W. H. P. Driessen, R. J. Giordano, A. Hajitou, et al. 2015. “Targeting the Interleukin-11 Receptor α in Metastatic Prostate Cancer: A First-in-Man Study.” Cancer 121 (14): 2411–2421.
  • Paul, S. R., F. Bennett, J. A. Calvetti, K. Kelleher, C. R. Wood, R. M. O’Hara, Jr., A. C. Leary, et al. 1990. “Molecular Cloning of a cDNA Encoding Interleukin 11, a Stromal Cell-Derived Lymphopoietic and Hematopoietic Cytokine.” Proceedings of the National Academy of Sciences of the United States of America 87 (19): 7512–7516..
  • Ponting, C. P., P. L. Oliver, and W. Reik. 2009. “Evolution and Functions of Long Noncoding RNAs.” Cell 136 (4): 629–641.
  • Putoczki, T. L., R. C. Dobson, and M. D. Griffin. 2014. “The Structure of Human Interleukin-11 Reveals Receptor-Binding Site Features and Structural Differences from Interleukin-6.” Acta Crystallographica Section D Biological Crystallography 70 (9): 2277–2285.
  • Putoczki, T. L., and M. Ernst. 2015. “IL-11 Signaling as a Therapeutic Target for Cancer.” Immunotherapy 7 (4): 441–453.
  • Putoczki, T. L., S. Thiem, A. Loving, R. A. Busuttil, N. J. Wilson, P. K. Ziegler, P. M. Nguyen, et al. 2013. “Interleukin-11 Is the Dominant IL-6 Family Cytokine during Gastrointestinal Tumorigenesis and Can Be Targeted Therapeutically.” Cancer Cell 24 (2): 257–271.
  • Quail, D. F., and J. A. Joyce. 2013. “Microenvironmental Regulation of Tumor Progression and Metastasis.” Nature Medicine 19 (11): 1423.
  • Sabry, D., O. O. Abdelaleem, E. M. Hefzy, A. A. Ibrahim, T. I. Ahmed, E. A. Hassan, N. D. Abdel-Hameed, and M. A. F. Khalil. 2018. “Interplay between Helicobacter pylori Infection, Interleukin-11, and Leukemia Inhibitory Factor in Gastric Cancer among Egyptian Patients.” Journal of Interferon & Cytokine Research 38 (11): 517–525.
  • Samaeekia, R., V. Adorno-Cruz, J. Bockhorn, Y. F. Chang, S. Huang, A. Prat, N. Ha, et al. 2017. “miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway.” Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 23 (4): 1091.
  • Sano, E., T. Takei, T. Ueda, and K. Tsumoto. 2017. “Production and Characterization of Genetically Modified Human IL-11 Variants.” Biochimica et Biophysica Acta (BBA) - General Subjects 1861 (2): 205–217.
  • Schafer, S.,. S. Viswanathan, A. A. Widjaja, W. W. Lim, A. Moreno-Moral, D. M. DeLaughter, B. Ng, et al. 2017. “IL-11 Is a Crucial Determinant of Cardiovascular Fibrosis.” Nature 552 (7683):110–115.
  • Shepelkova, G., V. Evstifeev, K. Majorov, I. Bocharova, and A. Apt. 2016. “Therapeutic Effect of Recombinant Mutated Interleukin 11 in the Mouse Model of Tuberculosis.” Journal of Infectious Diseases 214 (3): 496–501.
  • Singh, B., J. A. Berry, A. Shoher, and A. Lucci. 2006. “COX-2 Induces IL-11 Production in Human Breast Cancer Cells.” Journal of Surgical Research 131 (2): 267–275.
  • Sommer, J., T. Effenberger, E. Volpi, G. H. Waetzig, M. Bernhardt, J. Suthaus, C. Garbers, S. Rose-John, D. M. Floss, and J. Scheller. 2012. “Constitutively Active Mutant gp130 Receptor Protein from Inflammatory Hepatocellular Adenoma is Inhibited by an anti-gp130 Antibody That Specifically Neutralizes Interleukin 11 Signaling.” Journal of Biological Chemistry 287 (17): 13743–13751.
  • Sotiriou, C., M. Lacroix, L. Lespagnard, D. Larsimont, M. Paesmans, and J. J. Body. 2001. “Interleukins-6 and -11 Expression in Primary Breast Cancer and Subsequent Development of Bone Metastases.” Cancer Letters 169 (1): 87–95..
  • Sugimoto, M., T. Ohno, D. Y. Graham, and Y. Yamaoka. 2011. “Helicobacter pylori Outer Membrane Proteins on Gastric Mucosal Interleukin 6 and 11 Expression in Mongolian Gerbils.” Journal of Gastroenterology and Hepatology 26 (11): 1677–1684.
  • Tamura, Y., H. Kohno, T. Mohri, Y. Fujio, and G. Matsumiya. 2018. “The Cardioprotective Effect of Interleukin-11 against Ischemia-Reperfusion Injury in a Heart Donor Model.” Annals of Cardiothoracic Surgery 7 (1): 99–105.
  • Tao, L., G. Huang, R. Wang, Y. Pan, Z. He, X. Chu, H. Song, and L. Chen. 2016. “Cancer-Associated Fibroblasts Treated with Cisplatin Facilitates Chemoresistance of Lung Adenocarcinoma through IL-11/IL-11R/STAT3 Signaling Pathway.” Scientific Reports 6:38408.
  • Turley, S. J., V. Cremasco, and J. L. Astarita. 2015. “Immunological Hallmarks of Stromal Cells in the Tumour Microenvironment.” Nature Reviews Immunology 15 (11): 669.
  • Wan, B., H. Zhang, H. Fu, Y. Chen, L. Yang, J. Yin, Y. Wan, and Y. Shi. 2015. “Recombinant Human Interleukin-11 (IL-11) Is a Protective Factor in Severe Sepsis with Thrombocytopenia: A Case-Control Study.” Cytokine 76 (2): 138–143.
  • Wang, X., X. Che, C. Liu, Y. Fan, M. Bai, K. Hou, X. Shi, et al. 2018. “Cancer-Associated Fibroblasts-Stimulated Interleukin-11 Promotes Metastasis of Gastric Cancer Cells Mediated by Upregulation of MUC1.” Experimental Cell Research 368 (2):184–193.
  • Winship, A. L., M. Van Sinderen, J. Donoghue, K. Rainczuk, and E. Dimitriadis. 2016. “Targeting Interleukin-11 Receptor-a Impairs Human Endometrial Cancer Cell Proliferation and Invasion in Vitro and Reduces Tumor Growth and Metastasis in Vivo.” Molecular Cancer Therapeutics 15 (4): 720–730.
  • Xu, Y., J. Ye, M. Wang, Y. Wang, Q. Ji, Y. Huang, T. Zeng, et al. 2018. “Increased Interleukin-11 Levels in Thoracic Aorta and Plasma from Patients with Acute Thoracic Aortic Dissection.” Clinica Chimica Acta 481:193–199.
  • Yanaka, S., E. Sano, N. Naruse, K. Miura, M. Futatsumori-Sugai, J. M. Caaveiro, and K. Tsumoto. 2011. “Non-Core Region Modulates Interleukin-11 Signaling Activity: Generation of Agonist and Antagonist Variants.” Journal of Biological Chemistry 286 (10): 8085–8093.
  • Yang, L., Q. Gao, X. Wu, F. Feng, and K. Xu. 2018. “Long Noncoding RNA HEGBC Promotes Tumorigenesis and Metastasis of Gallbladder Cancer via Forming a Positive Feedback Loop with IL-11/STAT3 Signaling Pathway.” Journal of Experimental & Clinical Cancer Research 37 (1): 186.
  • Yuan, J. H., F. Yang, F. Wang, J. Z Ma, Y. J Guo, Q. F Tao, F. Liu, et al. 2014. “A Long Noncoding RNA Activated by TGF-β Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinoma.” Cancer Cell 25 (5): 666–681..
  • Zhang, X., N. Kiapour, S. Kapoor, J. R. Merrill, Y. Xia, W. Ban, S. M. Cohen, et al. 2018. “IL-11 Antagonist Suppresses Th17 Cell-Mediated Neuroinflammation and Demyelination in a Mouse Model of Relapsing-Remitting Multiple Sclerosis.” Clinical Immunology 197:45–53.
  • Zheng, T., M. H. Nathanson, and J. A. Elias. 1994. “Histamine Augments Cytokine-Stimulated IL-11 Production by Human Lung Fibroblasts.” Journal of Immunology 153 (10): 4742.
  • Zhou, W., W. Sun, M. M. H. Yung, S. Dai, Y. Cai, C. W. Chen, Y. Meng, et al. 2018. “Autocrine Activation of JAK2 by IL-11 Promotes Platinum Drug Resistance.” Oncogene 37 (29): 3981–3997.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.